Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NucleoBio Logo
NucleoBio CB Rank
452609
Heat Score
42
NucleoBio is the developer of diagnostics tools designed to detect non-invasive urological cancer
Founded
obfuscation
Private Yonkers, New York, United States www.nucleobio.net/
Biotechnology
Overview

NucleoBio
Heat Score
42

Growth Score
pts
in past quarter
Heat Score 42
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NucleoBio

CB Rank
452609
NucleoBio is the developer of diagnostics tools designed to detect non-invasive urological cancer
Founded
obfuscation
Private Yonkers, New York, United States www.nucleobio.net/
Biotechnology

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Charles Oyesile, Olorunseun Ogunwobi
About the Company
NucleoBio is the developer of diagnostics tools designed to detect non-invasive urological cancer. The company's diagnostics tools uses high-throughput genomic and proteomic profiling technologies via urinalysis assay, enabling physicians to detect new tumor development for prostate cancer.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Prostac® Diagnostic Lab Test
A molecular blood test that detects prostate cancer early and assesses its aggressiveness from a blood sample.
Prostac® "At Home" Sample Collection Kit
A kit for patients to collect urine samples at home and send them to a lab for prostate cancer testing.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Employee Profiles 2

Employee Profiles

News

News and Press

News•Sep 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$18.6KThis year, NucleoBio is projected to spend $18.6K on IT, according to Aberdeen.

Active Website Tech Count

3NucleoBio is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is NucleoBio's headquarters? NucleoBio is located in Yonkers, New York, United States.Who are NucleoBio's competitors? Alternatives and possible competitors to NucleoBio may include Veracyte, Guardant Health, and  Polaris Quantum Biotech.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|